SCHEMBL24197880

SCHEMBL24197880

COCc1ccc(N2CCNCC2)c(F)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 3/20 0.41
HTR3B O95264 3/20 0.41
HTR3A P46098 3/20 0.41
HTR3D Q70Z44 3/20 0.41
HTR3C Q8WXA8 3/20 0.41
HTR6 P50406 3/20 0.41
ADRB1 P08588 1/20 0.41
DRD2 P14416 1/20 0.41
CYP2C19 P33261 1/20 0.41
DRD3 P35462 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
LMNA P02545 2/20 0.40
MAPT P10636 1/20 0.40
HTR1A P08908 2/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
ALDH1A1 P00352 2/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30297103 0.75 ADRB1 (0.48) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL20037562 0.75 ADRB1 (0.48) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL8250845 0.72 HTR6 (0.54) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL24920523 0.72 ADRB1 (0.51) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL24198477 0.72 KDM4E (0.44) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL30484798 0.72 NCF1 (0.48) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL20255446 0.72 HTR7 (0.44) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL18291599 0.72 NCF1 (0.48) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL20249187 0.72 HTR6 (0.45) HTR3EHTR3BHTR3AHTR3DHTR3C
Hydrochloric Acid SCHEMBL26092566 0.71 KDM4E (0.46) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795158-B2 Chemical compounds ASTRAZENECA AB (SE) 2023-10-24 US disclosed
US-20220009901-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2022-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795158-B2 Chemical compounds CYP11B2, CYP11B1, CYP4B1 HTR3E 3239/4885HTR3B 2436/4885HTR3A 3394/4885
US-20220009901-A1 CHEMICAL COMPOUNDS CYP11B2, CYP11B1, CYP4B1 HTR3E 3239/4885HTR3B 2436/4885HTR3A 3394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.